未登录

F

Fumiaki Mori

Hirosaki University

H指数:57

被引数:9,984

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pathological and Molecular Insights into the Early Stage of Multiple System Atrophy

多系统萎缩早期阶段的病理学与分子学见解

Cells 2025, Vol. 14, Page 1966

IF5.2

2025-12-110

OAAI

Cerebrospinal fluid-driven extracellular vesicle as a potential diagnostic biomarker for multiple system atrophy

脑脊液驱动的细胞外囊泡作为多系统萎缩的潜在诊断生物标志物

Journal of the Neurological Sciences

IF3.2

2025-10-250

PRE

Morphological Changes in Direct Pathway Striatal Neurons in a Rat Model of Tardive Dyskinesia

直接通路纹状体神经元在迟发性运动障碍大鼠模型中的形态学变化

Movement Disorders

IF7.6

2025-10-020

OAAI

Routine intracoronary imaging-guided left main coronary intervention

SCIENTIFIC REPORTS

IF3.9

2025-03-190

OAAI

Effect of pre-procedural blood pressure on one-year cardiovascular events after percutaneous coronary intervention in patients with acute myocardial infarction

EUROPEAN HEART JOURNAL

IF35.6

2024-10-280

PRE

Intranasal administration of trehalose reduces α-synuclein oligomers and accelerates α-synuclein aggregation

BRAIN COMMUNICATIONS

IF4.5

2024-08-201

OAAI

Behavioral and histological analyses of the mouse Bassoon p.P3882A mutation corresponding to the human BSN p.P3866A mutation

FRONTIERS IN NEUROSCIENCE

IF3.2

2024-07-261

OAAI

The Masked Right Bundle Branch Block in the Setting of a Wide Complex Tachycardia

JACC-CLINICAL ELECTROPHYSIOLOGY

IF7.7

2024-07-010

PRE

Adverse clinical events after percutaneous coronary intervention in very elderly patients with acute coronary syndrome

CARDIOVASCULAR INTERVENTION AND THERAPEUTICS

IF5.8

2024-06-050

PRE

Colocalization of TDP-43 and stress granules at the early stage of TDP-43 aggregation in amyotrophic lateral sclerosis

肌萎缩侧索硬化TDP-43聚集早期TDP-43和应激颗粒的共定位

BRAIN PATHOLOGY

IF6.2

2023-10-044

OAAI

Axon terminal hypertrophy of striatal projection neurons with levodopa-induced dyskinesia priming

FRONTIERS IN NEUROSCIENCE

IF3.2

2023-06-070

OAAI

Effects of a Pharmacist-Led Educational Interventional Program on Electronic Monitoring-assessed Adherence to Direct Oral Anticoagulants: A Randomized, Controlled Trial in Patients with Nonvalvular Atrial Fibrillation

CLINICAL THERAPEUTICS

IF3.6

2022-11-015

PRE

Phosphorylation of Tau at Threonine 231 in Patients With Multiple System Atrophy and in a Mouse Model

多系统萎缩患者和小鼠模型中苏氨酸231的Tau磷酸化

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

IF3

2022-09-092

PRE

Pathological substrate of memory impairment in multiple system atrophy

多系统萎缩中记忆障碍的病理底物

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY

IF3.4

2022-08-1211

OA

Miki, Yasuo; Tanji, Kunikazu; Shinnai, Kana; Tanaka, Makoto T.; Altay, Firat; Foti, Sandrine C.; Strand, Catherine; Sasaki, Takanori; Kon, Tomoya; Shimoyama, Shuji; Furukawa, Tomonori; Nishijima, Haruo; Yamazaki, Hiromi; Asi, Yasmine T.; Bettencourt, Conceicao; Jaunmuktane, Zane; Tada, Mari; Mori, Fumiaki; Mizukami, Hiroki; Tomiyama, Masahiko; Lashuel, Hilal A.; Lashley, Tammaryn; Kakita, Akiyoshi; Ling, Helen; Lees, Andrew J.; Holton, Janice L.; Warner, Thomas T.; Wakabayashi, Koichi

Alteration of Vesicle-Associated Membrane Protein-Binding Protein B in α-Synuclein Aggregates in Lewy Body Disease

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

IF3

2022-08-112

PRE

Accumulation of Nonfibrillar TDP-43 in the Rough Endoplasmic Reticulum Is the Early-Stage Pathology in Amyotrophic Lateral Sclerosis

非纤维状TDP-43在粗面内质网中的积聚是肌萎缩性侧索硬化症的早期病理

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

IF3

2022-03-068

OA

Role of VAPB and vesicular profiles in α-synuclein aggregates in multiple system atrophy

BRAIN PATHOLOGY

IF6.2

2021-07-0110

OAAI

Effects of Aging on Levo-Dihydroxyphenylalanine-Induced Dyskinesia in a Rat Model of Parkinson's Disease

增龄对左旋二羟苯丙氨酸诱导的帕金森病大鼠运动障碍的影响

FRONTIERS IN AGING NEUROSCIENCE

IF4.5

2021-05-132

OAAI

Baseline low-density lipoprotein cholesterol predicts the benefit of adding ezetimibe on statin in statin-naive acute coronary syndrome

SCIENTIFIC REPORTS

IF3.9

2021-04-055

OAAI

One-year Outcome After PCI in Patients Treated Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers - Subanalysis From Multicenter Registry

IF38.6

2020-11-170

PRE